LONDON (Reuters) – Britain’s takeover watchdog unveiled proposals to make hostile bids harder but stopped short of endorsing the most radical proposals floated since Cadbury was taken over by Kraft Foods (KFT.N: Quote, Profile, Research, Stock Buzz).
Britain is one of the world’s most open regimes for takeovers and one of the biggest venues for dealmaking outside the United States.
LONDON, Oct 21 (Reuters) – Britain’s takeover watchdog
unveiled proposals to make hostile bids harder, but stopped
short of endorsing the most radical overhauls floated following
Kraft Food Inc’s (KFT.N: Quote, Profile, Research, Stock Buzz) controversial takeover of Cadbury.
The Takeover Panel’s proposals, which follow a far-reaching
consultation launched in June, include:
LONDON, Oct 20 (Reuters) – Citigroup Inc’s (C.N: Quote, Profile, Research, Stock Buzz) venture
capital arm and two other investors are planning to sell Amoun,
one of Egypt’s biggest drugmakers, three people familiar with
the matter said on Wednesday.
The owners — Citi Venture Capital International (CVCI),
together with the emerging-markets focused private equity arm
of the Capital Group Cos Inc, and Concord International
Investments — are close to hiring Goldman Sachs (GS.N: Quote, Profile, Research, Stock Buzz) to run
the sale, the people said.
LONDON, Oct 15 (Reuters) – Exponent, the British private
equity firm, is set to hire Rothschild [ROT.UL] to examine
strategic options for thetrainline — a move that could lead to
a 400 million pound-plus sale of the online ticket seller next
People familiar with the matter said the mandate could lead
to a sale to a strategic bidder or rival private equity firm, or
potentially a flotation. Any such move is unlikely to come
before mid-2011, they added.
LONDON, Oct 15 (Reuters) – Hedge funds have raised their
stakes in Wellstream Holdings Plc (WSML.L: Quote, Profile, Research, Stock Buzz), regulatory filings
show, suggesting they anticipate an improved approach for the
oil-pipes company that recently rebuffed General Electric
(GE.N: Quote, Profile, Research, Stock Buzz).
But their optimism appears at odds with Wellstream’s largest
investor, Schroders Plc (SDR.L: Quote, Profile, Research, Stock Buzz), which has sold two-fifths of
its stake, an example of so-called “top-slicing” where
traditional investors trim holdings during a takeover tussle to
lock in gains.
LONDON/PARIS (Reuters) – Private equity firms could jump in ahead of a planned flotation of Saint Gobain’s (SGOB.PA: Quote, Profile, Research, Stock Buzz) glass-bottle arm and seek a 4 billion euro-plus deal that would be Europe’s largest post-crisis buyout.
Late on Wednesday, the world’s largest building materials group outlined plans to list the unit, dubbed “Verallia,” in the second quarter of next year at the earliest.
AMSTERDAM/LONDON, Oct 13 (Reuters) – Infrastructure fund
manager Highstar Capital is looking to divest its 25 percent
stake in London City Airport, two people familiar with the
matter said, a sale that could fetch up to 200 million pounds
New York-based Highstar, which bought its stake in London’s
sole centrally located airport from Global Infrastructure
Partners (GIP) in 2008, is now looking for an exit and has
approached infrastructure and pension funds, the sources said.
LONDON, Oct 13 (Reuters) – Lazard Ltd (LAZ.N: Quote, Profile, Research, Stock Buzz) has hired
Naguib Kheraj for a new top international role, bolstering its
London offering with a banker previously linked with top jobs at
Lloyds Banking Group (LLOY.L: Quote, Profile, Research, Stock Buzz) and UK insurer Prudential (PRU.L: Quote, Profile, Research, Stock Buzz).
Kheraj, 46, had been chief executive officer (CEO) of
JPMorgan Cazenove, the U.S. bank’s joint venture with Britain’s
Cazenove Group. He left after JPMorgan (JPM.N: Quote, Profile, Research, Stock Buzz) took full control
of the unit earlier this year.
LONDON/ISTANBUL, Oct 12 (Reuters) – An arm of Citigroup
(C.N: Quote, Profile, Research, Stock Buzz) and two other investors are mulling a sale of copycat
drugmaker Biofarma, people familiar with the matter said, in
what could be Turkey’s biggest healthcare deal.
The generic drugmaker, whose full name is Biofarma
Pharmaceutical Industry Co Inc, has met investment bankers and
is close to picking advisers to help prepare the company for a
$500 million-plus sale, these people added. One said it could be
worth nearly $1 billion.
LONDON, Oct 11 (Reuters) – The editors of the Financial
Times, Guardian, Reuters and the Times urged Britain’s markets
watchdog to scrap “misguided” anti-leak rules that will curb
journalists’ contacts with bankers and executives.
Last month, the Financial Services Authority (FSA) told the
firms it regulates, such as banks, brokers and asset managers,
to adopt media policies to kill “strategic leaks.”